meglumine has been researched along with Mouth Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Confort, EM; da Costa, DC; da Silva, AF; Madeira, Mde F; Martins, AC; Moreira, JS; Palmeiro, MR; Quintella, LP; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM | 1 |
| Aguirre-Urizar, JM; Araluce-Iturbe, I; Crovetto-De la Torre, MA; Crovetto-Martínez, R; Orte-Aldea, C; Whyte-Orozco, J | 1 |
| Bagán, JV; Jiménez, Y; Milián, MA; Pérez, A; Scully, C | 1 |
3 other study(ies) available for meglumine and Mouth Diseases
| Article | Year |
|---|---|
Oral manifestations in the American tegumentary leishmaniasis.
Topics: Antiprotozoal Agents; Female; Humans; Larynx; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nose; Nose Diseases; Organometallic Compounds; Pharynx; Prognosis; Retrospective Studies | 2014 |
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Combined Modality Therapy; Diagnosis, Differential; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Nose Diseases; Organometallic Compounds | 2015 |
Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; Hepatitis C; Humans; Injections, Intravenous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Mouth Mucosa; Organometallic Compounds; Palate, Hard | 2002 |